Characterizing Prostate Cancer Risk Through Multi-ancestry Genome-wide Discovery of 187 Novel Risk Variants

The transferability and clinical value of genetic risk scores (GRSs) across populations remain limited due to an imbalance in genetic studies across ancestrally diverse populations. Here we conducted a multi-ancestry genome-wide association study of 156,319 prostate cancer cases and 788,443 controls of European, African, Asian and Hispanic men, reflecting a 57% increase in the number of non-European cases over previous prostate cancer genome-wide association studies. We identified 187 novel risk variants for prostate cancer, increasing the total number of risk variants to 451. An externally replicated multi-ancestry GRS was associated with risk that ranged from 1.8 (per standard deviation) in African ancestry men to 2.2 in European ancestry men. The GRS was associated with a greater risk of aggressive versus non-aggressive disease in men of African ancestry (P = 0.03). Our study presents novel prostate cancer susceptibility loci and a GRS with effective risk stratification across ancestry groups.

Citing Articles

Ancestry-Specific DNA Damage Repair Gene Mutations and Prostate Cancer.

Borbiev T, Babcock K, Sinopole K, Chesnut G, Petrovics G Cancers (Basel). 2025; 17(4).

PMID: 40002276 PMC: 11853348. DOI: 10.3390/cancers17040682.

Assessing the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 cases.

Mitchell J, Camacho N, Shea P, Stopsack K, Joseph V, Burren O Nat Commun. 2025; 16(1):1779.

PMID: 39971927 PMC: 11839991. DOI: 10.1038/s41467-025-56944-1.

ANO7 expression in the prostate modulates mitochondrial function and lipid metabolism.

Lof C, Sultana N, Goel N, Heron S, Wahlstrom G, House A Cell Commun Signal. 2025; 23(1):71.

PMID: 39923095 PMC: 11807338. DOI: 10.1186/s12964-025-02081-7.

Exploring the causal role of plasma metabolites and metabolite ratios in prostate cancer: a two-sample Mendelian randomization study.

Feng C, Li H, Zhang C, Zhou Y, Zhang H, Zheng P Front Mol Biosci. 2025; 11():1406055.

PMID: 39834784 PMC: 11743260. DOI: 10.3389/fmolb.2024.1406055.

Intersection of rare pathogenic variants from TCGA in the All of Us Research Program v6.

Bates B, Bates K, Boris S, Boris S, Wessman C, Stone D HGG Adv. 2025; 6(2):100405.

PMID: 39799398 PMC: 11830373. DOI: 10.1016/j.xhgg.2025.100405.

References

Gusev A, Ko A, Shi H, Bhatia G, Chung W, Penninx B . Integrative approaches for large-scale transcriptome-wide association studies. Nat Genet. 2016; 48(3):245-52. PMC: 4767558. DOI: 10.1038/ng.3506. View

Tian J, Wang Z, Mei S, Yang N, Yang Y, Ke J . CancerSplicingQTL: a database for genome-wide identification of splicing QTLs in human cancer. Nucleic Acids Res. 2018; 47(D1):D909-D916. PMC: 6324030. DOI: 10.1093/nar/gky954. View

Peltonen L, Altshuler D, de Bakker P, Deloukas P, Gabriel S, Gwilliam R . Integrating common and rare genetic variation in diverse human populations. Nature. 2010; 467(7311):52-8. PMC: 3173859. DOI: 10.1038/nature09298. View

Mancuso N, Gayther S, Gusev A, Zheng W, Penney K, Kote-Jarai Z . Large-scale transcriptome-wide association study identifies new prostate cancer risk regions. Nat Commun. 2018; 9(1):4079. PMC: 6172280. DOI: 10.1038/s41467-018-06302-1. View

Kurki M, Karjalainen J, Palta P, Sipila T, Kristiansson K, Donner K . FinnGen provides genetic insights from a well-phenotyped isolated population. Nature. 2023; 613(7944):508-518. PMC: 9849126. DOI: 10.1038/s41586-022-05473-8. View

Hoffmann T, Van Den Eeden S, Sakoda L, Jorgenson E, Habel L, Graff R . A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences. Cancer Discov. 2015; 5(8):878-91. PMC: 4527942. DOI: 10.1158/2159-8290.CD-15-0315. View

Wojcik G, Graff M, Nishimura K, Tao R, Haessler J, Gignoux C . Genetic analyses of diverse populations improves discovery for complex traits. Nature. 2019; 570(7762):514-518. PMC: 6785182. DOI: 10.1038/s41586-019-1310-4. View

Auton A, Brooks L, Durbin R, Garrison E, Kang H, Korbel J . A global reference for human genetic variation. Nature. 2015; 526(7571):68-74. PMC: 4750478. DOI: 10.1038/nature15393. View

. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015; 163(4):1011-25. PMC: 4695400. DOI: 10.1016/j.cell.2015.10.025. View

10.

Gamazon E, Wheeler H, Shah K, Mozaffari S, Aquino-Michaels K, Carroll R . A gene-based association method for mapping traits using reference transcriptome data. Nat Genet. 2015; 47(9):1091-8. PMC: 4552594. DOI: 10.1038/ng.3367. View

11.

Liu D, Zhu J, Zhou D, Nikas E, Mitanis N, Sun Y . A transcriptome-wide association study identifies novel candidate susceptibility genes for prostate cancer risk. Int J Cancer. 2021; 150(1):80-90. PMC: 8595764. DOI: 10.1002/ijc.33808. View

12.

Ruan Y, Lin Y, Feng Y, Chen C, Lam M, Guo Z . Improving polygenic prediction in ancestrally diverse populations. Nat Genet. 2022; 54(5):573-580. PMC: 9117455. DOI: 10.1038/s41588-022-01054-7. View

13.

Leitsalu L, Haller T, Esko T, Tammesoo M, Alavere H, Snieder H . Cohort Profile: Estonian Biobank of the Estonian Genome Center, University of Tartu. Int J Epidemiol. 2014; 44(4):1137-47. DOI: 10.1093/ije/dyt268. View

14.

Barfeld S, East P, Zuber V, Mills I . Meta-analysis of prostate cancer gene expression data identifies a novel discriminatory signature enriched for glycosylating enzymes. BMC Med Genomics. 2015; 7:513. PMC: 4351903. DOI: 10.1186/s12920-014-0074-9. View

15.

Newcombe P, Conti D, Richardson S . JAM: A Scalable Bayesian Framework for Joint Analysis of Marginal SNP Effects. Genet Epidemiol. 2016; 40(3):188-201. PMC: 4817278. DOI: 10.1002/gepi.21953. View

16.

Kachuri L, Hoffmann T, Jiang Y, Berndt S, Shelley J, Schaffer K . Genetically adjusted PSA levels for prostate cancer screening. Nat Med. 2023; 29(6):1412-1423. PMC: 10287565. DOI: 10.1038/s41591-023-02277-9. View

17.

Olama A, Dadaev T, Hazelett D, Li Q, Leongamornlert D, Saunders E . Multiple novel prostate cancer susceptibility signals identified by fine-mapping of known risk loci among Europeans. Hum Mol Genet. 2015; 24(19):5589-602. PMC: 4572072. DOI: 10.1093/hmg/ddv203. View

18.

Sun B, Maranville J, Peters J, Stacey D, Staley J, Blackshaw J . Genomic atlas of the human plasma proteome. Nature. 2018; 558(7708):73-79. PMC: 6697541. DOI: 10.1038/s41586-018-0175-2. View

19.

Mi Y, Zhao S, Zhang W, Zhang D, Weng J, Huang K . Down-regulation of Barx2 predicts poor survival in colorectal cancer. Biochem Biophys Res Commun. 2016; 478(1):67-73. DOI: 10.1016/j.bbrc.2016.07.091. View

20.

Das S, Forer L, Schonherr S, Sidore C, Locke A, Kwong A . Next-generation genotype imputation service and methods. Nat Genet. 2016; 48(10):1284-1287. PMC: 5157836. DOI: 10.1038/ng.3656. View